Pathology

Summary

Table of Contents

  • Publication date: February 2009
Keywords : cancer, lung cancer

China's demand for Lung Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Share

Pathology Industry in China : Latest Reports

Disease and Therapy Review: Prostate Cancer

Disease and Therapy Review: Prostate Cancer

  • $ 995
  • Industry report
  • February 2012
  • by Timely Data Resources, Inc.

The Prostate Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, ...

Disease and Therapy Review: Cervical Cancer

Disease and Therapy Review: Cervical Cancer

  • $ 995
  • Industry report
  • February 2012
  • by Timely Data Resources, Inc.

The Cervical Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, information on ...

Disease and Therapy Review: Lung Cancer

Disease and Therapy Review: Lung Cancer

  • $ 995
  • Industry report
  • December 2011
  • by Timely Data Resources, Inc.

Abstract The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information ...

Global Endometriosis Industry

March 2012 $ 4 600

Pathology Industry in China : Latest Downloads

Pharmaceutical Sector in China

Pharmaceutical Sector in China

  • Industry report
  • May 2012
  • 31 pages

... That nearly 100,000 people die annually from water pollution-related illnesses in china, and 75 percent of disease is linked to poor water quality. Recent scientific reports reveal that rates of liver ...

The Chinese Pharmaceutical Business

The Chinese Pharmaceutical Business

  • Industry report
  • March 2012
  • 22 pages

... Million) Astrazeneca is launching a direct-to-patients sales program for its breast cancer drug arimidex (around $450 at retail) Az S "arimidex direct" plan will offer u.S. Patients a month ...

Cancer Business  in Taiwan and China

Cancer Business in Taiwan and China

  • Industry report
  • January 2012
  • 8 pages
  • by Research Paper

... Of qsyqt at a concentration of 2.5% (V/v). Discussion patients with advanced malignancies, such as lung cancer, frequently develop cachexia that significantly affects clinical course, quality ...


Related Market Segments :

Cancer
Lung Cancer
Cancer Treatment

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.